Ara
Toplam kayıt 4, listelenen: 1-4
Thrombin-activatable fibrinolysis inhibitor and cardiovascular risk factors in polycystic ovary syndrome
(Johann Ambrosius Barth Verlag Medizinverlage Heidelberg Gmbh, 2008)
Objective: We aimed to assess circulating thrombin activatable fibrinolysis inhibitor (TAFI) levels and carotid intima-media thickness (CIMT) in PCOS patients and control sujects. in this study we aimed to evaluate the ...
Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin resistances
(Johann Ambrosius Barth Verlag Medizinverlage Heidelberg Gmbh, 2008)
Objective: Polycystic ovary syndrome is a syndrome of ovarian dysfunction. Oxidative stress, inflammation and endothelial cell activation are thought to play concomitant roles in the pathogenesis of the above diseases ...
The relationship of the interleukin-6-174 G > C gene polymorphism with oxidative stress markers in Turkish polycystic ovary syndrome patients
(Springer, 2008)
Objective. Interleukin-6 (IL-6) is a key pro-inflammatory and immune-modulatory cytokine of relevance for cardiovascular (CID) diseases. Cardiovascular risk factors that have been reported include oxydative stress markers ...
The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome
(Elsevier Science Bv, 2004)
Objective: The aim of the study was to compare the bone mineral density (BMD) measurements between the patients with polycystic ovary syndrome (PCOS) and age and the body mass index (BMI) matched healthy controls, and to ...